Skip to main content
. 2021 May 3;36(18):e132. doi: 10.3346/jkms.2021.36.e132

Table 5. Early symptoms associated with severe cases requiring oxygen therapy.

Variables Univariate model Multivariate model 1a Multivariate model 2b Multivariate model 3c
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Sex
Male vs. female 1.3 (1.1–1.5) 1.6 (1.3–1.9) 1.5 (1.3–1.8) 1.6 (1.4–2.0)
Age (yr)
60–69 vs. 0–59 4.3 (3.4–5.3) 2.9 (2.2–3.7) 3.2 (2.5–4.0) 3.2 (2.6–4.1)
70–79 vs. 0–59 9.5 (7.6–11.9) 5.8 (4.4–7.6) 6.6 (5.1–8.5) 7.0 (5.4–9.1)
≥ 80 vs. 0–59 22.5 (17.3–29.4) 15.8 (11.2–22.2) 16.0 (11.7–21.8) 20.6 (14.9–28.4)
No. of comorbidities
1–2 vs. 0 4.6 (3.9–5.5) 2.0 (1.6–2.5) 2.1 (1.7–2.6) 2.1 (1.7–2.6)
≥ 3 vs. 0 13.5 (9.9–18.4) 3.6 (2.4–5.3) 3.4 (2.3–4.9) 3.6 (2.5–5.3)
No. of symptoms on admission
1 vs. 0 1.6 (1.2–2.0) 1.7 (1.3–2.3)
2 vs. 0 1.5 (1.2–2.0) 1.8 (1.3–2.4)
≥ 3 vs. 0 2.9 (2.3–3.6) 3.6 (2.7–4.8)
Fever
Yes vs. No 2.8 (2.4–3.3) 2.5 (1.8–3.4)
Cough
Yes vs. No 1.3 (1.2–1.6) 1.2 (1.0–1.5)
Sputum
Yes vs. No 1.5 (1.2–1.7) 1.2 (0.9–1.5)
Sore throat
Yes vs. No 0.5 (0.4–0.7) 0.7 (0.5–1.0)
Rhinorrhea
Yes vs. No 0.6 (0.4–0.8) 0.6 (0.4–0.9) 0.8 (0.5–1.1)
Myalgia
Yes vs. No 1.1 (0.9–1.4) 1.2 (0.9–1.5)
Fatigue
Yes vs. No 2.0 (1.5–2.7) 1.3 (0.9–1.9)
Dyspnea
Yes vs. No 8.9 (7.4–10.7) 6.9 (5.5–8.7)
Headache
Yes vs. No 0.8 (0.6–1.0) 0.7 (0.6–1.0) 1.0 (0.8–1.3)
Altered mental status
Yes vs. No 15.4 (6.8–34.7) 4.2 (1.5–11.7)
Nausea or vomiting
Yes vs. No 2.0 (1.5–2.7) 1.1 (0.8–1.7)
Diarrhea
Yes vs. No 1.3 (1.1–1.7) 1.2 (0.9–1.7)
Systolic BP (mmHg)
≥ 120 vs. < 120 1.2 (1.0–1.5) 0.9 (0.7–1.2) 0.9 (0.7–1.2) 0.9 (0.7–1.1)
Diastolic BP (mmHg)
≥ 80 vs. < 80 0.8 (0.7–0.9) 0.9 (0.7–1.1) 0.8 (0.7–1.0) 0.8 (0.7–1.0)
Heart rate (bpm)
≥ 120 vs. < 120 2.7 (1.8–4.0) 1.8 (1.1–3.0) 2.3 (1.5–3.6) 2.3 (1.5–3.7)
Body temperature (°C)
≥ 37.5 vs. < 37.5 2.9 (2.4–3.4) 1.4 (1.0–2.1) 3.6 (2.9–4.4) 2.5 (2.0–3.2)

OR = odds ratio, CI = confidence interval, BP = blood pressure, COVID-19 = coronavirus disease 2019.

aLogistic regression model for severe COVID-19 requiring supplemental oxygen therapy as the dependent variable and the presence of each symptom on admission as the main predictor variable (C-statistics = 0.87, P value for the Hosmer-Lemeshow test = 0.914); bLogistic regression model for severe COVID-19 requiring supplemental oxygen therapy as the dependent variable and the presence of rhinorrhea and headache on admission as the main predictor variables (C-statistics = 0.83, P value for the Hosmer-Lemeshow test = 0.080); cLogistic regression model for severe COVID-19 requiring supplemental oxygen therapy as the dependent variable and the number of symptoms prevalent on admission as the main predictor variable (C-statistics = 0.84, P value for the Hosmer-Lemeshow test = 0.143).